Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33510 | 124 | 20.7 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
889 | 2 | FLUOROQUINOLONES//QUINOLONES//CIPROFLOXACIN | 11411 |
33510 | 1 | PRULIFLOXACIN//RUFLOXACIN//ULIFLOXACIN | 124 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PRULIFLOXACIN | authKW | 3835161 | 23% | 54% | 29 |
2 | RUFLOXACIN | authKW | 2518504 | 12% | 68% | 15 |
3 | ULIFLOXACIN | authKW | 1866342 | 10% | 63% | 12 |
4 | CAS 112984 60 8 | authKW | 985019 | 3% | 100% | 4 |
5 | CAS 123447 62 1 | authKW | 985019 | 3% | 100% | 4 |
6 | NM394 | authKW | 788013 | 3% | 80% | 4 |
7 | CENTPROPAZINE | authKW | 738764 | 2% | 100% | 3 |
8 | NM441 PHARMACOKINETICS | authKW | 738764 | 2% | 100% | 3 |
9 | NM441 | authKW | 492509 | 2% | 100% | 2 |
10 | PRULIFLOXACIN ACTIVE METABOLITE LABORATORY ANIMALS | authKW | 492509 | 2% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1730 | 68% | 0% | 84 |
2 | Microbiology | 390 | 24% | 0% | 30 |
3 | Infectious Diseases | 273 | 15% | 0% | 18 |
4 | Chemistry, Analytical | 272 | 21% | 0% | 26 |
5 | Chemistry, Medicinal | 95 | 9% | 0% | 11 |
6 | Biochemical Research Methods | 34 | 6% | 0% | 8 |
7 | Respiratory System | 22 | 4% | 0% | 5 |
8 | Oncology | 21 | 9% | 0% | 11 |
9 | Medical Laboratory Technology | 8 | 2% | 0% | 2 |
10 | Toxicology | 8 | 3% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CATTEDRA MICROBIOL MED | 246255 | 1% | 100% | 1 |
2 | KONKAN GYANPEETH ENGN | 246255 | 1% | 100% | 1 |
3 | MED SURGMATER DOMINI UNIV HOSPCHAIR P | 246255 | 1% | 100% | 1 |
4 | PHARM ANALYT BIOANALYT CHEM | 246255 | 1% | 100% | 1 |
5 | UNIT PHARMACOL LEONARDO DONATELLI | 246255 | 1% | 100% | 1 |
6 | ACRAF SPA | 123126 | 1% | 50% | 1 |
7 | HEADQUARTERS MED | 123126 | 1% | 50% | 1 |
8 | FDZ IRCCS | 82084 | 1% | 33% | 1 |
9 | PHTHISIOL P DIS | 82084 | 1% | 33% | 1 |
10 | INSPECT TESTING | 61562 | 1% | 25% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEMOTHERAPY | 6213 | 6% | 0% | 8 |
2 | CLINICAL DRUG INVESTIGATION | 2815 | 4% | 0% | 5 |
3 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2664 | 13% | 0% | 16 |
4 | MULTIDISCIPLINARY RESPIRATORY MEDICINE | 2575 | 2% | 1% | 2 |
5 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 1434 | 6% | 0% | 8 |
6 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 1025 | 3% | 0% | 4 |
7 | JOURNAL OF CHEMOTHERAPY | 891 | 2% | 0% | 3 |
8 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 664 | 2% | 0% | 2 |
9 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 614 | 2% | 0% | 3 |
10 | INFECTION | 586 | 2% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PRULIFLOXACIN | 3835161 | 23% | 54% | 29 | Search PRULIFLOXACIN | Search PRULIFLOXACIN |
2 | RUFLOXACIN | 2518504 | 12% | 68% | 15 | Search RUFLOXACIN | Search RUFLOXACIN |
3 | ULIFLOXACIN | 1866342 | 10% | 63% | 12 | Search ULIFLOXACIN | Search ULIFLOXACIN |
4 | CAS 112984 60 8 | 985019 | 3% | 100% | 4 | Search CAS+112984+60+8 | Search CAS+112984+60+8 |
5 | CAS 123447 62 1 | 985019 | 3% | 100% | 4 | Search CAS+123447+62+1 | Search CAS+123447+62+1 |
6 | NM394 | 788013 | 3% | 80% | 4 | Search NM394 | Search NM394 |
7 | CENTPROPAZINE | 738764 | 2% | 100% | 3 | Search CENTPROPAZINE | Search CENTPROPAZINE |
8 | NM441 PHARMACOKINETICS | 738764 | 2% | 100% | 3 | Search NM441+PHARMACOKINETICS | Search NM441+PHARMACOKINETICS |
9 | NM441 | 492509 | 2% | 100% | 2 | Search NM441 | Search NM441 |
10 | PRULIFLOXACIN ACTIVE METABOLITE LABORATORY ANIMALS | 492509 | 2% | 100% | 2 | Search PRULIFLOXACIN+ACTIVE+METABOLITE+LABORATORY+ANIMALS | Search PRULIFLOXACIN+ACTIVE+METABOLITE+LABORATORY+ANIMALS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GIANNARINI, G , TASCINI, C , SELLI, C , (2009) PRULIFLOXACIN: CLINICAL STUDIES OF A BROAD-SPECTRUM QUINOLONE AGENT.FUTURE MICROBIOLOGY. VOL. 4. ISSUE 1. P. 13-24 | 21 | 64% | 11 |
2 | LOCATELLI, M , DE LUTIIS, F , CARLUCCI, G , (2013) HIGH PERFORMANCE LIQUID CHROMATOGRAPHY DETERMINATION OF PRULIFLOXACIN AND FIVE RELATED IMPURITIES IN PHARMACEUTICAL FORMULATIONS.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 78-79. ISSUE . P. 27-33 | 17 | 71% | 4 |
3 | IMBIMBO, BP , KLIETMANN, W , BROCCALI, GP , CESANA, M , AARONS, L , (1997) POPULATION PHARMACOKINETICS OF RUFLOXACIN IN PATIENTS WITH ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS.EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 5. ISSUE 1. P. 37-42 | 20 | 95% | 2 |
4 | LOCATELLI, M , CIFELLI, R , CARLUCCI, G , ROMAGNOLI, A , (2016) STABILITY STUDY OF PRULIFLOXACIN AND ULIFLOXACIN IN HUMAN PLASMA BY HPLC-DAD.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 31. ISSUE 1. P. 106 -111 | 17 | 61% | 0 |
5 | FENG, WH , ZHANG, CX , ZHANG, Y , LI, HT , ZHANG, HH , YIN, WY , (2014) DETERMINATION OF ULIFLOXACIN, THE ACTIVE METABOLITE OF PRULIFLOXACIN IN HUMAN PLASMA BY HPLC: APPLICATION TO A PHARMACOKINETIC STUDY.LATIN AMERICAN JOURNAL OF PHARMACY. VOL. 33. ISSUE 5. P. 785 -789 | 10 | 83% | 1 |
6 | RAFAILIDIS, PI , POLYZOS, KA , SGOUROS, K , FALAGAS, ME , (2011) PRULIFLOXACIN: A REVIEW FOCUSING ON ITS USE BEYOND RESPIRATORY AND URINARY TRACT INFECTIONS.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 37. ISSUE 4. P. 283 -290 | 18 | 46% | 7 |
7 | PRIVITERA, G , NICASTRO, G , IMBIMBO, BP , CESANA, M , VISCONTI, M , LOMBARDI, F , TAGLIABUE, G , FALESCHINI, E , COLTURANI, F , FRANZINI, P , ET AL (1993) BILIARY-EXCRETION OF RUFLOXACIN IN HUMANS.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 37. ISSUE 12. P. 2545-2549 | 17 | 81% | 1 |
8 | FRITSCHE, TR , BIEDENBACH, DJ , JONES, RN , (2009) ANTIMICROBIAL ACTIVITY OF PRULIFLOXACIN TESTED AGAINST A WORLDWIDE COLLECTION OF GASTROENTERITIS-PRODUCING PATHOGENS, INCLUDING THOSE CAUSING TRAVELER'S DIARRHEA.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 53. ISSUE 3. P. 1221 -1224 | 10 | 77% | 8 |
9 | PERRY, G , MANT, TGK , MORRISON, PJ , SACKS, S , WOODCOOK, J , WISE, R , IMBIMBO, BP , (1993) PHARMACOKINETICS OF RUFLOXACIN IN PATIENTS WITH IMPAIRED RENAL-FUNCTION.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 37. ISSUE 4. P. 637-641 | 14 | 93% | 7 |
10 | CHEN, YC , YANG, HP , LU, GS , WU, XF , HUANG, WX , WU, YM , LV, XJ , WU, GM , ZHANG, GF , LI, Q , ET AL (2012) PRULIFLOXACIN VERSUS LEVOFLOXACIN IN THE TREATMENT OF RESPIRATORY AND URINARY TRACT INFECTIONS: A MULTICENTRE, DOUBLE-BLIND, RANDOMIZED CONTROLLED CLINICAL TRIAL.CHEMOTHERAPY. VOL. 58. ISSUE 3. P. 249-256 | 11 | 65% | 1 |
Classes with closest relation at Level 1 |